{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:20:46Z","timestamp":1775060446989,"version":"3.50.1"},"reference-count":32,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.1248\/bpb.b21-00463","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T22:15:05Z","timestamp":1633040105000},"page":"1551-1556","source":"Crossref","is-referenced-by-count":1,"title":["Proteomics Analysis of Lymphatic Metastasis-Related Proteins Using Highly Metastatic Human Melanoma Cells Originated by Sequential <i>in Vivo<\/i> Implantation"],"prefix":"10.1248","volume":"44","author":[{"given":"Katsuyuki","family":"Chida","sequence":"first","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asa","family":"Ohtani","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumio","family":"Ohtsuki","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Akita","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Chiba University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sporn MB. The war on cancer. Lancet<\/i>, 347<\/b>, 1377\u20131381 (1996).","DOI":"10.1016\/S0140-6736(96)91015-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Pillar N, Polsky AL, Weissglas-Volkov D, Shomron N. Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness. Cell Death Dis.<\/i>, 9<\/b>, 1040 (2018).","DOI":"10.1038\/s41419-018-1094-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lowery FJ, Yu D. Brain metastasis: Unique challenges and open opportunities. Biochim. Biophys. Acta Rev. Cancer<\/i>, 1867<\/b>, 49\u201357 (2017).","DOI":"10.1016\/j.bbcan.2016.12.001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Yoneda T, Sasaki A, Mundy GR. Osteolytic bone metastasis in breast cancer. Breast Cancer Res. Treat.<\/i>, 32<\/b>, 73\u201384 (1994).","DOI":"10.1007\/BF00666208"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Chopra A, Sharma R, Rao UNM. Pathology of melanoma. Surg. Clin. North Am.<\/i>, 100<\/b>, 43\u201359 (2020).","DOI":"10.1016\/j.suc.2019.09.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Masuda T, Tomita M, Ishihama Y. Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. J. Proteome Res.<\/i>, 7<\/b>, 731\u2013740 (2008).","DOI":"10.1021\/pr700658q"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption\/ionization, nanoelectrospray, and LC\/MS sample pretreatment in proteomics. Anal. Chem.<\/i>, 75<\/b>, 663\u2013670 (2003).","DOI":"10.1021\/ac026117i"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Masuda T, Saito N, Tomita M, Ishihama Y. Unbiased quantitation of Escherichia coli<\/i> membrane proteome using phase transfer surfactants. Mol. Cell. Proteomics<\/i>, 8<\/b>, 2770\u20132777 (2009).","DOI":"10.1074\/mcp.M900240-MCP200"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc.<\/i>, 4<\/b>, 44\u201357 (2009).","DOI":"10.1038\/nprot.2008.211"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia<\/i>, 19<\/b>, 649\u2013658 (2017).","DOI":"10.1016\/j.neo.2017.05.002"},{"key":"11","unstructured":"11) Fidler IJ. Biological behavior of malignant melanoma cells correlated to their survival in vivo.<\/i> Cancer Res.<\/i>, 35<\/b>, 218\u2013224 (1975)."},{"key":"12","unstructured":"12) Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin. Cancer Res.<\/i>, 2<\/b>, 1627\u20131636 (1996)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Tominaga N, Kosaka N, Ono M, Katsuda T, Yoshioka Y, Tamura K, Lotvall J, Nakagama H, Ochiya T. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood\u2013brain barrier. Nat. Commun.<\/i>, 6<\/b>, 6716 (2015).","DOI":"10.1038\/ncomms7716"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Valiente M, Van Swearingen AED, Anders CK, et al.<\/i> Brain metastasis cell lines panel: a public resource of organotropic cell lines. Cancer Res.<\/i>, 80<\/b>, 4314\u20134323 (2020).","DOI":"10.1158\/0008-5472.CAN-20-0291"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hiraga T, Ninomiya T. Establishment and characterization of a C57BL\/6 mouse model of bone metastasis of breast cancer. J. Bone Miner. Metab.<\/i>, 37<\/b>, 235\u2013242 (2019).","DOI":"10.1007\/s00774-018-0927-y"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ball DK, Rachfal AW, Kemper SA, Brigstock DR. The heparin-binding 10\u2009kDa fragment of connective tissue growth factor (CTGF) containing module 4 alone stimulates cell adhesion. J. Endocrinol.<\/i>, 176<\/b>, R1\u2013R7 (2003).","DOI":"10.1677\/joe.0.176r001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nguyen TQ, Goldschmeding R. Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis? Pharm. Res.<\/i>, 25<\/b>, 2416\u20132426 (2008).","DOI":"10.1007\/s11095-008-9548-9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wu HM, Shen QY, Fang L, Zhang SH, Shen PT, Liu YJ, Liu RY. JNK-TLR9 signal pathway mediates allergic airway inflammation through suppressing melatonin biosynthesis. J. Pineal Res.<\/i>, 60<\/b>, 415\u2013423 (2016).","DOI":"10.1111\/jpi.12323"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kumari A, Shonibare Z, Monavarian M, Arend RC, Lee NY, Inman GJ, Mythreye K. TGFbeta signaling networks in ovarian cancer progression and plasticity. Clin. Exp. Metastasis<\/i>, 38<\/b>, 139\u2013161 (2021).","DOI":"10.1007\/s10585-021-10077-z"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol.<\/i>, 20<\/b>, 69\u201384 (2019).","DOI":"10.1038\/s41580-018-0080-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kang E, Seo J, Yoon H, Cho S. The post-translational regulation of epithelial-mesenchymal transition-inducing transcription factors in cancer metastasis. Int. J. Mol. Sci.<\/i>, 22<\/b>, 3591 (2021).","DOI":"10.3390\/ijms22073591"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Puisieux A, Brabletz T, Caramel J. Oncogenic roles of EMT-inducing transcription factors. Nat. Cell Biol.<\/i>, 16<\/b>, 488\u2013494 (2014).","DOI":"10.1038\/ncb2976"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Santibanez JF. Transforming growth factor-beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer. ISRN Dermatol.<\/i>, 2013<\/b>, 597927 (2013).","DOI":"10.1155\/2013\/597927"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Huang Y, Noble NA. PAI-1 as a target in kidney disease. Curr. Drug Targets<\/i>, 8<\/b>, 1007\u20131015 (2007).","DOI":"10.2174\/138945007781662373"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Cartier-Michaud A, Malo M, Charriere-Bertrand C, Gadea G, Anguille C, Supiramaniam A, Lesne A, Delaplace F, Hutzler G, Roux P, Lawrence DA, Barlovatz-Meimon G. Matrix-bound PAI-1 supports cell blebbing via<\/i> RhoA\/ROCK1 signaling. PLOS ONE<\/i>, 7<\/b>, e32204 (2012).","DOI":"10.1371\/journal.pone.0032204"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Falk S, Bonneau F, Ebert J, Kogel A, Conti E. Mpp6 incorporation in the nuclear exosome contributes to RNA channeling through the Mtr4 helicase. Cell Reports<\/i>, 20<\/b>, 2279\u20132286 (2017).","DOI":"10.1016\/j.celrep.2017.08.033"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Chlebowski A, Lubas M, Jensen TH, Dziembowski A. RNA decay machines: the exosome. Biochim. Biophys. Acta<\/i>, 1829<\/b>, 552\u2013560 (2013).","DOI":"10.1016\/j.bbagrm.2013.01.006"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Tagaya M, Arasaki K, Inoue H, Kimura H. Moonlighting functions of the NRZ (mammalian Dsl1) complex. Front. Cell Dev. Biol.<\/i>, 2<\/b>, 25 (2014).","DOI":"10.3389\/fcell.2014.00025"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Yang Z, Tulu US, Wadsworth P, Rieder CL. Kinetochore dynein is required for chromosome motion and congression independent of the spindle checkpoint. Curr. Biol.<\/i>, 17<\/b>, 973\u2013980 (2007).","DOI":"10.1016\/j.cub.2007.04.056"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Xu J, Zhao M, Huang S, Wu Q, Bai M, Zhao X, Wang J, Hu Y, Feng J, Zhang Z. RINT1 is a new suppression target to reduce colon cancer cell growth, migration and invasion through regulating ZW10\/NAG-1 expression. Mol. Cell. Biochem.<\/i>, (2020), in press.","DOI":"10.1007\/s11010-020-03858-9"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Morley SC. The actin-bundling protein L-plastin: a critical regulator of immune cell function. Int. J. Cell Biol.<\/i>, 2012<\/b>, 935173 (2012).","DOI":"10.1155\/2012\/935173"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Otsuka M, Kato M, Yoshikawa T, Chen H, Brown EJ, Masuho Y, Omata M, Seki N. Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis. Biochem. Biophys. Res. Commun.<\/i>, 289<\/b>, 876\u2013881 (2001).","DOI":"10.1006\/bbrc.2001.6047"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/10\/44_b21-00463\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T07:08:55Z","timestamp":1633158535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/10\/44_b21-00463\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b21-00463","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"article-number":"b21-00463"}}